Summary: A new hybrid of biomaterial nanoparticles in conjunction with existing methods of tissue regeneration was successfully synthesized to promote and regenerate tissue following spinal cord injury. The new method has the potential to treat spinal cord injuries.
Source: University of Limerick
Unique new material developed at University of Limerick (UL) in Ireland has shown significant promise in the treatment of spinal cord injury.
Brand new research conducted at UL’s Bernal Institute—published in the journal Biomaterials Research—has made exciting progress in the field of spinal cord tissue repair.
New hybrid biomaterials developed at UL in the form of nanoparticles and building on existing practice in the tissue engineering field were successfully synthesized to promote repair and regeneration following spinal cord injury, according to the researchers.
The UL team led by Professor Maurice N Collins, Associate Professor, School of Engineering at UL, and lead author Aleksandra Serafin, a Ph.D. candidate at UL, used a new kind of scaffolding material and a unique new electrically conducting polymer composite to promote new tissue growth and generation that could advance the treatment of spinal cord injury.
“Spinal cord injury remains one of the most debilitating traumatic injuries a person can sustain during their lifetime, affecting every aspect of the person’s life,” explained Professor Collins.
“The debilitating disorder results in paralysis below the level of injury, and in the US alone, the annual health care costs for SCI patient care are $9.7 billion. As there is currently no widely available treatment, continuous research into this field is crucial to find a treatment to improve the patient’s quality of life, with the research field turning towards tissue engineering for novel treatment strategies.
“The field of tissue engineering aims to solve the global problem of shortages of donated organs and tissues, in which a new trend has emerged in the form of conductive biomaterials. Cells in the body are affected by electrical stimulation, especially cells of a conductive nature such as cardiac or nerve cells,” Professor Collins explained.
The research team describes a growing interest in the use of electroconductive tissue engineered scaffolds that has emerged due to the improved cell growth and proliferation when cells are exposed to a conductive scaffold.
“Raising the conductivity of biomaterials to develop such treatment strategies typically centers on the addition of conductive components such as carbon nanotubes or conductive polymers such as PEDOT:PSS, which is a commercially available conductive polymer that has been used to date in the tissue engineering field.” explained lead author Alexandra Serafin.
“Unfortunately, severe limitations persist when using the PEDOT:PSS polymer in biomedical applications. The polymer relies on the PSS component to allow it to be water soluble, but when this material is implanted in the body, it displays poor biocompatibility.
This means that upon exposure to this polymer, the body has potential toxic or immunological responses, which are not ideal in an already damaged tissue which we are trying to regenerate. This severely limits which hydrogel components can be successfully incorporated to create conductive scaffolds,” she added.
Novel PEDOT nanoparticles (NPs) were developed in the study to overcome this limitation. Synthesis of conductive PEDOT NPs allows for the tailored modification of the surface of the NPs to achieve desired cell response and increasing the variability of which hydrogel components can be incorporated, without the required presence of PSS for water solubility.
In this work, hybrid biomaterials comprised of gelatin and immunomodulatory hyaluronic acid, a material which Professor Collins has developed over many years at UL, was combined with the developed novel PEDOT NPs to create biocompatible electroconductive scaffolds for targeted spinal cord injury repair.
A complete study of the structure, property, and function relationships of these precisely designed scaffolds for optimized performance at the site of injury was carried out, including in-vivo research with rat spinal cord injury models, undertaken by Ms. Serafin during a Fulbright research exchange to the University of California San Diego Neuroscience Department, which was a partner on the project.
The introduction of the PEDOT NPs into the biomaterial increased the conductivity of samples. In addition, the mechanical properties of implanted materials should mimic the tissue of interest in tissue engineered strategies, with the developed PEDOT NP scaffolds matching the mechanical values of the native spinal cord,” explained the researchers.
Biological response to the developed PEDOT NP scaffolds were studied with stem cells in vitro and in animal models of spinal cord injury in vivo. Excellent stem cell attachment and growth on the scaffolds was observed, they reported.
Testing showed greater axonal cell migration towards the site of spinal cord injury, into which the PEDOT NP scaffold was implanted, as well as lower levels of scarring and inflammation than in the injury model which had no scaffold, according to the study.
Overall, these results show the potential of these materials for spinal cord repair, says the research team.
“The impact that spinal cord injury has on a patient’s life is not only physical, but also psychological, since it can severely affect the patient’s mental health, resulting in increased incidence of depression, stress, or anxiety,” explained Ms. Serafin.
“Treating spinal injuries will therefore not only allow the patient to walk or move again but will allow them to live their lives to their full potential, which makes projects such as this one so vital to the research and medical communities.
In addition, the overall societal impact in providing an effective treatment to spinal cord injuries will lead to a reduction in health care costs associated with treating patients. These results offer encouraging prospects for patients and further research into this area is planned.
“Studies have shown that the excitability threshold of motor neurons on the distal end of a spinal cord injury tends to be higher. A future project will further improve the scaffold design and create conductivity gradients in the scaffold, with the conductivity increasing towards the distal end of the lesion to further stimulate neurons to regenerate,” she added.
About this spinal cord injury research news
Author: Press Office
Source: University of Limerick
Contact: Press Office – University of Limerick
Image: The image is in the public domain
Original Research: openaccess.
“Electroconductive PEDOT nanoparticle integrated scaffolds for spinal cord tissue repair” by Aleksandra Serafin et al. Biomaterials Research
Electroconductive PEDOT nanoparticle integrated scaffolds for spinal cord tissue repair
Hostile environment around the lesion site following spinal cord injury (SCI) prevents the re-establishment of neuronal tracks, thus significantly limiting the regenerative capacity. Electroconductive scaffolds are emerging as a promising option for SCI repair, though currently available conductive polymers such as polymer poly(3,4-ethylenedioxythiophene) polystyrene sulfonate (PEDOT:PSS) present poor biofunctionality and biocompatibility, thus limiting their effective use in SCI tissue engineering. (TE) treatment strategies.
PEDOT NPs were synthesized via chemical oxidation polymerization in miniemulsion. The conductive PEDOT NPs were incorporated with gelatin and hyaluronic acid (HA) to create gel:HA:PEDOT-NPs scaffolds. Morphological analysis of both PEDOT NPs and scaffolds was conducted via SEM. Further characterization included dielectric constant and permittivity variances mapped against morphological changes after crosslinking, Young’s modulus, FTIR, DLS, swelling studies, rheology, in-vitro, and in-vivo biocompatibility studies were also conducted.
Incorporation of PEDOT NPs increased the conductivity of scaffolds to 8.3 × 10–4 ± 8.1 x 10–5S/cm. The compressive modulus of the scaffold was tailored to match the native spinal cord at 1.2 ± 0.2 MPa, along with controlled porosity. Rheological studies of the hydrogel showed excellent 3D shear-thinning printing capabilities and shape fidelity post-printing. In vitro studies showed the scaffolds are cytocompatible and an in vivo assessment in a rat SCI lesion model shows glial fibrillary acidic protein (GFAP) upregulation not directly in contact with the lesion/implantation site, with diminished astrocyte reactivity. Decreased levels of macrophage and microglia reactivity at the implant site is also observed. This positively influences the re-establishment of signals and initiation of healing mechanisms. Observation of axon migration towards the scaffold can be attributed to immunomodulatory properties of HA in the scaffold caused by a controlled inflammatory response. HA limits astrocyte activation through its CD44 receptors and therefore limits scar formation. This allows for a superior axonal migration and growth towards the targeted implantation site through the provision of a stimulating microenvironment for regeneration.
Based on these results, the incorporation of PEDOT NPs into Gel:HA biomaterial scaffolds enhances not only the conductive capabilities of the material, but also the provision of a healing environment around lessons in SCI. Hence, gel:HA:PEDOT-NPs scaffolds are a promising TE option for stimulating regeneration for SCI.